Research & Development



  他說這話的時候是面對鏡頭的,雖然人們看不到他的表情,但似乎可以從露出來的那雙眼楮里看到有某種莫名的情緒在涌動。   “我真的看到了啊,刷地一下就紅了。”說到這女生停頓了下,有些驕傲︰“估計是因為看到了我。”亚洲在线AV极品无码   “還有你剛剛為什麼要騙我?難道說你是怕我來了會掩蓋你的光芒?”婷婷五月亚洲av   “薯片要吃嗎?”   “前面qz家粉絲臉真大,SCL的何修拿全球總決賽MVP的時候洛洛怕還是個菜鳥哦。”美国a片   陸昔年放棄掙扎,事實擺在眼前,辯無可辯。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo